“Long-Term Safety and Efficacy of Tralokinumab in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years”. SKIN The Journal of Cutaneous Medicine 9, no. 2 (March 17, 2025): s573. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/3392.